Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of...

Full description

Bibliographic Details
Main Authors: Sonja Grosskinsky, Melanie Schott, Christiane Brenner, Sally J Cutler, Peter Kraiczy, Peter F Zipfel, Markus M Simon, Reinhard Wallich
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2654920?pdf=render
_version_ 1819129590698737664
author Sonja Grosskinsky
Melanie Schott
Christiane Brenner
Sally J Cutler
Peter Kraiczy
Peter F Zipfel
Markus M Simon
Reinhard Wallich
author_facet Sonja Grosskinsky
Melanie Schott
Christiane Brenner
Sally J Cutler
Peter Kraiczy
Peter F Zipfel
Markus M Simon
Reinhard Wallich
author_sort Sonja Grosskinsky
collection DOAJ
description Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever.
first_indexed 2024-12-22T08:46:08Z
format Article
id doaj.art-1eabcba06ef24a34aed47b994fb2dcad
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T08:46:08Z
publishDate 2009-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1eabcba06ef24a34aed47b994fb2dcad2022-12-21T18:32:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-01-0143e485810.1371/journal.pone.0004858Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.Sonja GrosskinskyMelanie SchottChristiane BrennerSally J CutlerPeter KraiczyPeter F ZipfelMarkus M SimonReinhard WallichBorrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates. Here we identify for the first time a multifunctional surface lipoprotein of B. recurrentis, termed HcpA, and demonstrate that it binds human complement regulators, Factor H, CFHR-1, and simultaneously, the host protease plasminogen. Cell surface bound factor H was found to retain its activity and to confer resistance to complement attack. Moreover, ectopic expression of HcpA in a B. burgdorferi B313 strain, deficient in Factor H binding proteins, protected the transformed spirochetes from complement-mediated killing. Furthermore, HcpA-bound plasminogen/plasmin endows B. recurrentis with the potential to resist opsonization and to degrade extracellular matrix components. Together, the present study underscores the high virulence potential of B. recurrentis. The elucidation of the molecular basis underlying the versatile strategies of B. recurrentis to escape innate immunity and to persist in human tissues, including the brain, may help to understand the pathological processes underlying louse-borne relapsing fever.http://europepmc.org/articles/PMC2654920?pdf=render
spellingShingle Sonja Grosskinsky
Melanie Schott
Christiane Brenner
Sally J Cutler
Peter Kraiczy
Peter F Zipfel
Markus M Simon
Reinhard Wallich
Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
PLoS ONE
title Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
title_full Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
title_fullStr Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
title_full_unstemmed Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
title_short Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.
title_sort borrelia recurrentis employs a novel multifunctional surface protein with anti complement anti opsonic and invasive potential to escape innate immunity
url http://europepmc.org/articles/PMC2654920?pdf=render
work_keys_str_mv AT sonjagrosskinsky borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT melanieschott borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT christianebrenner borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT sallyjcutler borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT peterkraiczy borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT peterfzipfel borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT markusmsimon borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity
AT reinhardwallich borreliarecurrentisemploysanovelmultifunctionalsurfaceproteinwithanticomplementantiopsonicandinvasivepotentialtoescapeinnateimmunity